prazosin has been researched along with Altitude Hypoxia in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Altitude Hypoxia: Low ambient oxygen tension associated with ALTITUDE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insulin sensitivity was reduced in HA-Pla (C-ISI: 4." | 1.31 | Women at altitude: short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity. ( Braun, B; Butterfield, GE; Fulco, CS; Mazzeo, RS; Moore, LG; Muza, SR; Rock, PB; Wolfel, GE; Zamudio, S, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, B | 1 |
| Rock, PB | 1 |
| Zamudio, S | 1 |
| Wolfel, GE | 1 |
| Mazzeo, RS | 1 |
| Muza, SR | 1 |
| Fulco, CS | 1 |
| Moore, LG | 1 |
| Butterfield, GE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cardiovascular and Metabolic Physiological Adaptations to Intermittent Hypoxia. Physiological Aspects and Expression of Receptors and Cellular Mediators[NCT02058823] | Phase 4 | 12 participants (Actual) | Interventional | 2013-08-07 | Terminated (stopped due to budget constraints) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for prazosin and Altitude Hypoxia
| Article | Year |
|---|---|
Women at altitude: short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Altitude; Altitude Sickness; Blood Glucose; C-Peptid | 2001 |